Home / Butylscopolamine / Norway
NO ATC A03BB01 · updated 2 Nov 2026
Butylscopolamine shortage in Norway
Is there a Butylscopolamine shortage in Norway?
Yes. As of 2 Nov 2026, 1 Butylscopolamine product is reported short in Norway, the first since 18 Aug 2026. The company estimate for the return is 31 Dec 2026. Main reason: increased demand.
Also short in Italy, Belgium. All countries.
Affected products in Norway
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| NO | Buscopan 20 mg/ml injeksjonsvæske, oppløsning, 5 x 1 ml ampulle | Opella Healthcare France SAS | 18 Aug 2026 | 31 Dec 2026 | Increased demand Uventet økt etterspørsel |
Source
DMP (Norwegian Medical Products Agency). Official list. Ongoing and announced shortages reported by companies; one row per pack (varenummer).